Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Personalized Cell Therapy Global Market Report 2025
Request Sample Buy Now
Global Personalized Cell Therapy Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Personalized Cell Therapy Global Market Report 2025

By Cell Type (Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, Other Cell Type), By Technique (Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions, Organ Transplantation), By Application (Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer, Other Applications), By End-User (Hospital, Homecare, Specialty Clinics, Other End-User) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Personalized Cell Therapy Market Overview

• Personalized Cell Therapy market size has reached to $17.11 billion in 2024

• Expected to grow to $46.24 billion in 2029 at a compound annual growth rate (CAGR) of 22.1%

• Growth Driver: Rising Neurological Disorders Fuel Growth In The Personalized Cell Therapy Market

• Market Trend: Strategic Partnerships Driving Innovation And Safety in the Personalized Cell Therapy Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Cell Therapy Market?

Personalized cell therapy refers to a type of medical treatment where a patient's own cells, or cells that are specifically tailored to them, are used to treat a disease or condition. This therapy is customized to the individual's unique biological profile, often involving the modification or manipulation of cells to enhance their therapeutic potential. The key advantage of personalized cell therapy is that it minimizes the risk of rejection and adverse reactions as the therapy is designed to be compatible with the patient's own body.

The main types of personalized cell therapy include lymphocytes, mesenchymal stem cells, Hematopoietic Stem Cells, and others. Lymphocytes are a type of white blood cell that are part of the immune system and help the body fight disease. It uses various techniques such as platelet transfusions, bone marrow transplantation, packed red cell transfusions, and organ transplantation and is applied for cardiovascular diseases, neurological disorders, inflammatory diseases, diabetes, cancer, and others. It is used by various end-users, including hospitals, homecare, specialty clinics, and others.

Personalized Cell Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Personalized Cell Therapy Market Size 2025 And Growth Rate?

The personalized cell therapy market size has grown exponentially in recent years. It will grow from $17.11 billion in 2024 to $20.83 billion in 2025 at a compound annual growth rate (CAGR) of 21.8%. The growth in the historic period can be attributed to increasing awareness of personalized medicine, increasing healthcare spending, increasing government initiatives, increasing funding for clinical research, rise in neurological disorders.

What Is The Personalized Cell Therapy Market Growth Forecast?

The personalized cell therapy market size is expected to see exponential growth in the next few years. It will grow to $46.24 billion in 2029 at a compound annual growth rate (CAGR) of 22.1%. The growth in the forecast period can be attributed to rising clinical trials, rising incidence of chronic illnesses, growing geriatric population, rising prevalence of cancer, and increasing adoption of regenerative medicines. Major trends in the forecast period include technological advancements, integration of AI, personalized vaccines, bioinformatics, and microfluidic technologies.

The forecast of 22.1% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. advancement in regenerative medicine by inflating prices of autologous cell processing systems and gene-editing reagents developed in Germany and South Korea, resulting in delayed treatments and higher regenerative therapy program costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Personalized Cell Therapy Market Segmented?

1) By Cell Type: Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, Other Cell Type

2) By Technique: Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions, Organ Transplantation

3) By Application: Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer, Other Applications

4) By End-User: Hospital, Homecare, Specialty Clinics, Other End-User

Subsegments:

1) By Lymphocytes: T Cells, Natural Killer (NK) Cells, Regulatory T Cells

2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs, Adipose Tissue-Derived MSCs, Umbilical Cord-Derived MSCs

3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells, Allogeneic Hematopoietic Stem Cells

4) By Other Cell Types: Dendritic Cells, Fibroblasts, Endothelial Cells

What Is Driving The Personalized Cell Therapy Market? Rising Neurological Disorders Fuel Growth In The Personalized Cell Therapy Market

The rise in neurological disorders is expected to drive the growth of the personalized cell therapy market going forward. Neurological disorders are a group of conditions affecting the brain, spinal cord, and nerves, leading to symptoms such as impaired motor function, cognitive deficits, and sensory disturbances. Neurological disorders are occurring due to an aging population, environmental stressors, and lifestyle changes contributing to higher incidences of neurodegenerative diseases. Personalized cell therapy is required for neurological disorders as it offers tailored treatments that target specific patient needs, potentially restoring damaged neural tissue and improving outcomes in complex, individualized conditions. For instance, in December 2022, according to the Parkinson Foundation, a US-based government organization, the yearly incidence of Parkinson's disease (PD) among older persons is 50% greater than the existing estimate of 60,000 cases. Additionally, 1.2 million more Americans are predicted to have Parkinson's disease by 2030. Therefore, the rise in neurological disorders is driving the growth of the personalized cell therapy industry.

Who Are The Major Players In The Global Personalized Cell Therapy Market?

Major companies operating in the personalized cell therapy marker are AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd., Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc.

What Are The Key Trends Of The Global Personalized Cell Therapy Market? Strategic Partnerships Driving Innovation And Safety in the Personalized Cell Therapy Market

Major companies operating in the personalized cell therapy market are focused on forming strategic partnerships to accelerate the development and commercialization of innovative therapies. These collaborations help companies pool resources, expertise, and technologies to enhance research and development capabilities, streamline clinical trials, and navigate regulatory pathways more efficiently. For instance, in October 2022, Century Therapeutics Inc., a US-based biotechnology company, partnered with Bristol Myers Squibb (BMS), a US-based biopharmaceutical company, to develop and commercialize allogeneic cell therapies. This collaboration uses Century's innovative induced pluripotent stem cell (iPSC) technology to create engineered natural killer (NK) and T cell therapies to treat hematologic malignancies and solid tumors. The agreement encompasses the development of up to four distinct cell therapy programs, with the initial focus on two specific areas: acute myeloid leukemia (AML) and multiple myeloma. These programs will utilize engineered NK cells or gamma delta T cells derived from iPSCs.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Personalized Cell Therapy Market? Fujifilm Corp. Expands CDMO Capabilities With The Acquisition Of Atara Biotherapeutics' Cell Therapy Manufacturing Facility

In April 2022, Fujifilm Corp., a Japan-based manufacturer of biopharmaceuticals, acquired a cell therapy manufacturing facility from Atara Biotherapeutics Inc. for USD 100 million. The key aims of the acquisition are to expand Fujifilm's CDMO capabilities in advanced therapies, strengthen its manufacturing capacity and expertise, and support Atara's clinical pipeline. Atara is a US-based allogeneic T-cell immunotherapy company.

What Is The Regional Outlook For The Global Personalized Cell Therapy Market?

North America was the largest region in the personalized cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Cell Therapy Market?

The personalized cell therapy market consists of revenues earned by entities by providing services such as c car-t cell therapy, stem cell transplantation, tissue regeneration, gene editing therapies and immunotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized cell therapy market also includes sales of personalized cancer vaccines, cell therapy kits and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Personalized Cell Therapy Industry?

The personalized cell therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cell therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Personalized Cell Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $20.83 billion
Revenue Forecast In 2034 $46.24 billion
Growth Rate CAGR of 22.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Cell Type: Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, Other Cell Type
2) By Technique: Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions, Organ Transplantation
3) By Application: Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer, Other Applications
4) By End-User: Hospital, Homecare, Specialty Clinics, Other End-User Subsegments: 1) By Lymphocytes: T Cells, Natural Killer (NK) Cells, Regulatory T Cells
2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs, Adipose Tissue-Derived MSCs, Umbilical Cord-Derived MSCs
3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells, Allogeneic Hematopoietic Stem Cells
4) By Other Cell Types: Dendritic Cells, Fibroblasts, Endothelial Cells
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd, Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Personalized Cell Therapy Market Characteristics

3. Personalized Cell Therapy Market Trends And Strategies

4. Personalized Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Personalized Cell Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Personalized Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Personalized Cell Therapy Market Growth Rate Analysis

5.4. Global Personalized Cell Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Personalized Cell Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Personalized Cell Therapy Total Addressable Market (TAM)

6. Personalized Cell Therapy Market Segmentation

6.1. Global Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lymphocytes

Mesenchymal Stem Cell

Hematopoietic Stem Cell

Other Cell Type

6.2. Global Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Platelet Transfusions

Bone Marrow Transplantation

Packed Red Cell Transfusions

Organ Transplantation

6.3. Global Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cardiovascular Diseases

Neurological Disorders

Inflammatory Diseases

Diabetes

Cancer

Other Applications

6.4. Global Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Homecare

Specialty Clinics

Other End-User

6.5. Global Personalized Cell Therapy Market, Sub-Segmentation Of Lymphocytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

T Cells

Natural Killer (NK) Cells

Regulatory T Cells

6.6. Global Personalized Cell Therapy Market, Sub-Segmentation Of Mesenchymal Stem Cells (MSCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bone Marrow-Derived MSCs

Adipose Tissue-Derived MSCs

Umbilical Cord-Derived MSCs

6.7. Global Personalized Cell Therapy Market, Sub-Segmentation Of Hematopoietic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Autologous Hematopoietic Stem Cells

Allogeneic Hematopoietic Stem Cells

6.8. Global Personalized Cell Therapy Market, Sub-Segmentation Of Other Cell Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dendritic Cells

Fibroblasts

Endothelial Cells

7. Personalized Cell Therapy Market Regional And Country Analysis

7.1. Global Personalized Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Personalized Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Cell Therapy Market

8.1. Asia-Pacific Personalized Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Cell Therapy Market

9.1. China Personalized Cell Therapy Market Overview

9.2. China Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Cell Therapy Market

10.1. India Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Cell Therapy Market

11.1. Japan Personalized Cell Therapy Market Overview

11.2. Japan Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Cell Therapy Market

12.1. Australia Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Cell Therapy Market

13.1. Indonesia Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Cell Therapy Market

14.1. South Korea Personalized Cell Therapy Market Overview

14.2. South Korea Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Cell Therapy Market

15.1. Western Europe Personalized Cell Therapy Market Overview

15.2. Western Europe Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Cell Therapy Market

16.1. UK Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Cell Therapy Market

17.1. Germany Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Cell Therapy Market

18.1. France Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Cell Therapy Market

19.1. Italy Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Cell Therapy Market

20.1. Spain Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Cell Therapy Market

21.1. Eastern Europe Personalized Cell Therapy Market Overview

21.2. Eastern Europe Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Cell Therapy Market

22.1. Russia Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Cell Therapy Market

23.1. North America Personalized Cell Therapy Market Overview

23.2. North America Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Cell Therapy Market

24.1. USA Personalized Cell Therapy Market Overview

24.2. USA Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Cell Therapy Market

25.1. Canada Personalized Cell Therapy Market Overview

25.2. Canada Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Cell Therapy Market

26.1. South America Personalized Cell Therapy Market Overview

26.2. South America Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Cell Therapy Market

27.1. Brazil Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Cell Therapy Market

28.1. Middle East Personalized Cell Therapy Market Overview

28.2. Middle East Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Cell Therapy Market

29.1. Africa Personalized Cell Therapy Market Overview

29.2. Africa Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Cell Therapy Market Competitive Landscape And Company Profiles

30.1. Personalized Cell Therapy Market Competitive Landscape

30.2. Personalized Cell Therapy Market Company Profiles

30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Cipla Limited Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Cell Therapy Market Other Major And Innovative Companies

31.1. Poseida Therapeutics Inc.

31.2. Sangamo Therapeutics Inc.

31.3. Nkarta Therapeutics Inc.

31.4. Intellia Therapeutics Inc.

31.5. Tessa Therapeutics Pte Ltd

31.6. Atara Biotherapeutics Inc.

31.7. Adaptimmune Therapeutics plc

31.8. Precision BioSciences Inc.

31.9. Editas Medicine Inc.

31.10. Cellectis S.A.

31.11. Gracell Biotechnologies Inc.

31.12. Mesoblast Limited

31.13. Fate Therapeutics Inc.

31.14. Athersys Inc.

31.15. Bellicum Pharmaceuticals Inc.

32. Global Personalized Cell Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Cell Therapy Market

34. Recent Developments In The Personalized Cell Therapy Market

35. Personalized Cell Therapy Market High Potential Countries, Segments and Strategies

35.1 Personalized Cell Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Personalized Cell Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Personalized Cell Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Personalized Cell Therapy Market, Sub-Segmentation Of Lymphocytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Personalized Cell Therapy Market, Sub-Segmentation Of Mesenchymal Stem Cells (MSCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Personalized Cell Therapy Market, Sub-Segmentation Of Hematopoietic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Personalized Cell Therapy Market, Sub-Segmentation Of Other Cell Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Personalized Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Personalized Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: AbbVie Inc. Financial Performance
  • Table 80: Bristol-Myers Squibb Company Financial Performance
  • Table 81: GlaxoSmithKline plc Financial Performance
  • Table 82: Gilead Sciences Inc. Financial Performance
  • Table 83: Cipla Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Personalized Cell Therapy Market, Sub-Segmentation Of Lymphocytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Personalized Cell Therapy Market, Sub-Segmentation Of Mesenchymal Stem Cells (MSCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Personalized Cell Therapy Market, Sub-Segmentation Of Hematopoietic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Personalized Cell Therapy Market, Sub-Segmentation Of Other Cell Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Personalized Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Personalized Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: AbbVie Inc. Financial Performance
  • Figure 80: Bristol-Myers Squibb Company Financial Performance
  • Figure 81: GlaxoSmithKline plc Financial Performance
  • Figure 82: Gilead Sciences Inc. Financial Performance
  • Figure 83: Cipla Limited Financial Performance

Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

Read More About Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous ...

View Report

Cell Therapy Technologies Global Market Report 2025 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distributi...

View Report

Soil Amendments Global Market Report 2025 – By Soil Type (Clay, Sand, Loam, Silt), By Crop Type (Cereals And Grains, Oilseeds And Pulses, Fruits And vegetables, Other Crop Types), By Product (Organic, Inorganic), By Form...

View Report

Stem Cell Therapy Global Market Report 2025 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application ...

View Report

Prescription Lens Global Market Report 2025 – By Type (Single Vision, Bifocal, Trifocal, Progressive, Active, Other Types), By Coating (Anti-Reflective, Scratch Resistant Coating, Anti-Fog Coating, Ultraviolet Treatment)...

View Report

Retail Digital Transformation Global Market Report 2025 – By Accessibility (Mobile Application, Website), By Technology (Cloud Computing, Big Data, Artificial intelligence, Internet Of Things (IoT), Augmented Reality (AR...

View Report

Gout Therapeutics Global Market Report 2025 – By Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics), By Treatment (Xanthine Oxidase Inhibitor, Uricosuria Medication), By Disease Condition (Ac...

View Report

Skin Care Stores Global Market Report 2025 – By Product Type (Facial Care, Lip Care, Body Care), By Packaging Type (Tubes, Jars, Bottles), By Category (Premium Skin Care Products, Mass Skin Care Products), By Gender (Fem...

View Report

Frequently Asked Questions

Personalized cell therapy refers to a type of medical treatment where a patient's own cells, or cells that are specifically tailored to them, are used to treat a disease or condition. This therapy is customized to the individual's unique biological profile, often involving the modification or manipulation of cells to enhance their therapeutic potential. The key advantage of personalized cell therapy is that it minimizes the risk of rejection and adverse reactions as the therapy is designed to be compatible with the patient's own body. For further insights on this market, request a sample here

The market major growth driver - Rising Neurological Disorders Fuel Growth In The Personalized Cell Therapy Market. For further insights on this market, request a sample here

The personalized cell therapy market size has grown exponentially in recent years. It will grow from $17.11 billion in 2024 to $20.83 billion in 2025 at a compound annual growth rate (CAGR) of 21.8%. The growth in the historic period can be attributed to increasing awareness of personalized medicine, increasing healthcare spending, increasing government initiatives, increasing funding for clinical research, rise in neurological disorders. The personalized cell therapy market size is expected to see exponential growth in the next few years. It will grow to " $46.24 billion in 2029 at a compound annual growth rate (CAGR) of 22.1%. The growth in the forecast period can be attributed to rising clinical trials, rising incidence of chronic illnesses, growing geriatric population, rising prevalence of cancer, and increasing adoption of regenerative medicines. Major trends in the forecast period include technological advancements, integration of AI, personalized vaccines, bioinformatics, and microfluidic technologies. For further insights on this market, request a sample here

The personalized cell therapymarket covered in this report is segmented –
1) By Cell Type: Lymphocytes; Mesenchymal Stem Cell; Hematopoietic Stem Cell; Other Cell Type
2) By Technique: Platelet Transfusions; Bone Marrow Transplantation; Packed Red Cell Transfusions; Organ Transplantation
3) By Application: Cardiovascular Diseases; Neurological Disorders; Inflammatory Diseases; Diabetes; Cancer; Other Applications
4) By End-User: Hospital; Homecare; Specialty Clinics; Other End-User Subsegments:
1) By Lymphocytes: T Cells; Natural Killer (NK) Cells; Regulatory T Cells
2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs; Adipose Tissue-Derived MSCs; Umbilical Cord-Derived MSCs
3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells; Allogeneic Hematopoietic Stem Cells
4) By Other Cell Types: Dendritic Cells; Fibroblasts; Endothelial Cells For further insights on this market, request a sample here

North America was the largest region in the personalized cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cell therapy marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the personalized cell therapy marker are AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd., Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc. . For further insights on this market, request a sample here.

Major trends in this market include Strategic Partnerships Driving Innovation And Safety in the Personalized Cell Therapy Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Personalized Cell Therapy Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon